GS-8670
/ Gilead
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 16, 2025
GS-8670: An Intestinally Targeted Farnesoid X Receptor Agonist Restoring Barrier Integrity and Demonstrating Robust Efficacy in Colitis Models
(ECCO-IBD 2026)
- No abstract available
Clinical • Immunology • Inflammatory Bowel Disease
1 to 1
Of
1
Go to page
1